Evidence overview
Turmeric
Turmeric is the whole-rhizome source of curcumin and other curcuminoids. The supplement literature heavily overlaps with the curcumin literature because most modern turmeric supplements are standardized to curcuminoid content. The research base concentrates on osteoarthritis, inflammatory markers, lipid profiles, and metabolic markers. Bioavailability of oral curcumin is the single most-discussed practical question for this supplement.
Most studied for
Coverage pending
PubMed coverage
Coverage pending
Safety profile
In your full report
Mechanism class
Whole-rhizome extract of the turmeric plant (Curcuma longa). Active compounds are the curcuminoid family...
Study coverage
Study coverage by goal
PubMed counts for Turmeric grouped by the goal each study targets.
Evidence overview is temporarily unavailable for Turmeric.
Evidence
What the evidence covers
The terrain of the published literature, not its conclusions.
Turmeric (Curcuma longa) is the whole-rhizome source of the curcuminoid family of compounds; the supplement literature heavily overlaps with the curcumin literature because most modern trials standardize the dose to curcuminoid content. Active compounds include curcumin (the most-studied), demethoxycurcumin, bisdemethoxycurcumin, and various volatile oils. The clinical literature spans osteoarthritis (where the supplement has substantial evidence and is included in some clinical practice positions), inflammatory and antioxidant biomarkers, lipid profiles, metabolic markers in type 2 diabetes and metabolic syndrome, mood including depression, ulcerative colitis, and many other conditions in smaller research streams.
The outcome dimensions covered most heavily are osteoarthritis (the most-asked consumer use, with multiple meta-analyses supporting symptomatic benefit), inflammatory and antioxidant biomarkers (the mechanistic basis underlying most claimed benefits), lipid profiles, metabolic markers in type 2 diabetes and metabolic syndrome, mood (depression in particular), and skin and dermatologic conditions. The 2024 comprehensive synthesis covering 103 RCTs across 42 health outcomes represents the supplement-overall scope of the literature better than any single goal-specific meta-analysis.
Demographically, the literature is unusually broad across populations and conditions, a function of curcumin's pleiotropic mechanism. Bioavailability is the central practical question: oral curcumin has very poor absorption, which is why most modern supplemental formulations include absorption enhancers (piperine, phospholipid complexes like Meriva, micellar formulations, or nanoparticle-delivery systems). Form choice meaningfully affects what dose actually reaches systemic circulation, and trial results depend substantially on the formulation used.
Safety
Safety summary
Common adverse events, drug interactions, and special populations.
Turmeric is generally well-tolerated at typical supplemental doses. The most-common adverse effects are gastrointestinal: nausea, abdominal discomfort, and (at high doses) diarrhea. Concerns have been raised in the recent literature about rare cases of drug-induced liver injury associated with concentrated curcumin supplements, particularly those with absorption-enhancing formulations; the absolute risk appears low but the trend is documented in pharmacovigilance reports across multiple countries. Drug interactions include theoretical additive effects with anticoagulants (based on platelet-function effects), reduced absorption of iron, and a debated interaction with chemotherapy agents (an ongoing topic in oncology). People with gallstones, on anticoagulants, or undergoing chemotherapy should consult a clinician.
This summary is informational and not medical advice. Consult a clinician before starting or changing any supplement, especially if you take prescription medications.
Foundations
Foundation of the evidence base
A few studies the field anchors on. Not the full picture, just the starting points.
Comprehensive systematic review covering 103 RCTs across 42 health outcomes, the most-thorough supplement-overall reference for curcumin/turmeric in the literature. Functions as the field's umbrella synthesis when discussing the supplement broadly.
View on PubMedGRADE-assessed systematic review and meta-analysis on the core antioxidant and anti-inflammatory mechanisms that underpin most claimed health benefits. The methodological reference for turmeric's mechanistic claims.
View on PubMedMeta-analysis specifically on turmeric and curcumin for arthritis, the supplement's most-asked consumer use case. Establishes the field reference for this primary clinical application.
View on PubMed
Limitations
What this page doesn't answer
Where the public summary stops and the personalized report begins.
This page summarizes the turmeric literature at a general level. It does not address which formulation (standardized curcuminoids vs. absorption-enhanced products like Meriva, BCM-95, or piperine-co-administered) is right for your specific goal, what dose to use given the chosen formulation, how absorption considerations affect your case, or how turmeric interacts with the medications you take (especially anticoagulants and chemotherapy agents). Bioavailability is the single most-consequential variable in this supplement's evidence base, which makes the personalized report especially useful here.
Personalized to you
Get a personalized Turmeric report
Your free first report adds the things this page doesn't: per-goal evidence breakdown, demographic-specific findings, full citation list, and a safety section tailored to your profile.
Free first report. No credit card. Cancel anytime.
Get notified when new evidence appears
We'll email you when the literature on Turmeric materially updates. No account required.